12,251
Total Claims
$3.4M
Drug Cost
826
Beneficiaries
$4,090
Cost/Patient
Peer Comparison vs. 8,961 Nephrology providers
+219%
Cost per patient vs peers
$4,090 vs $1,283 avg
+196%
Brand preference vs peers
26.5% vs 9.0% avg
Opioid Prescribing
0.1%
Opioid Rate
16
Opioid Claims
$524
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
74% generic
Brand: 3,208 claims · $2.9M
Generic: 8,891 claims · $425K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 470 | $503K |
| Dapagliflozin Propanediol | 438 | $394K |
| Sitagliptin Phosphate | 196 | $244K |
| Dulaglutide | 140 | $217K |
| Semaglutide | 127 | $166K |
| Finerenone | 181 | $166K |
| Sodium Zirconium Cyclosilicate | 169 | $158K |
| Sucroferric Oxyhydroxide | 44 | $139K |
| Apixaban | 98 | $103K |
| Patiromer Calcium Sorbitex | 80 | $97K |
| Sevelamer Carbonate | 244 | $93K |
| Sevelamer Carbonate | 37 | $69K |
| Linagliptin | 53 | $53K |
| Cinacalcet Hcl | 29 | $52K |
| Sitagliptin Phos/Metformin Hcl | 30 | $44K |
Prescribing Profile
Patient Profile
75
Avg Age
54%
Female
2.47
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About